Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2011 (2011), Article ID 405437, 15 pages
http://dx.doi.org/10.1155/2011/405437
Review Article

Chondrosarcoma: With Updates on Molecular Genetics

1Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea
2Department of Pathology, Weill Medical College of Cornell University, The Methodist Hospital, Houston, TX 77030, USA

Received 14 September 2010; Revised 23 November 2010; Accepted 17 December 2010

Academic Editor: C. Verhoef

Copyright © 2011 Mi-Jung Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. D. M. Fletcher, K. K. Unni, and F. Mertens, World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone, IARC Press, Lyon, France, 2002.
  2. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2006,” Ca: A Cancer Journal for Clinicians, vol. 56, no. 2, pp. 106–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. D. Murphey, E. A. Walker, A. J. Wilson, M. J. Kransdorf, H. T. Temple, and F. H. Gannon, “From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation,” Radiographics, vol. 23, no. 5, pp. 1245–1278, 2003. View at Google Scholar · View at Scopus
  4. A. Y. Giuffrida, J. E. Burgueno, L. G. Koniaris, J. C. Gutierrez, R. Duncan, and S. P. Scully, “Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database,” Journal of Bone and Joint Surgery. American, vol. 91, no. 5, pp. 1063–1072, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. D. Murphey, D. J. Flemming, S. R. Boyea, J. A. Bojescul, D. E. Sweet, and H. T. Temple, “Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features,” Radiographics, vol. 18, no. 5, pp. 1213–1237, 1998. View at Google Scholar · View at Scopus
  6. D. J. Flemming and M. D. Murphey, “Enchondroma and chondrosarcoma,” Seminars in Musculoskeletal Radiology, vol. 4, no. 1, pp. 59–71, 2000. View at Google Scholar · View at Scopus
  7. M. U. A. Geirnaardt, J. Hermans, J. L. Bloem et al., “Usefulness of radiography in differentiating enchondroma from central grade I chondrosarcoma,” American Journal of Roentgenology, vol. 169, no. 4, pp. 1097–1104, 1997. View at Google Scholar · View at Scopus
  8. M. J. A. Geirnaerdt, J. L. Bloem, F. Eulderink, P. C. W. Hogendoorn, and A. H. M. Taminiau, “Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings,” Radiology, vol. 186, no. 3, pp. 813–817, 1993. View at Google Scholar · View at Scopus
  9. M. J. A. Geirnaerdt, P. C. W. Hogendoorn, J. L. Bloem, A. H. M. Taminiau, and H. J. van der Woude, “Cartilaginous tumors: fast contrast-enhanced MR imaging,” Radiology, vol. 214, no. 2, pp. 539–546, 2000. View at Google Scholar · View at Scopus
  10. H. L. Evans, A. G. Ayala, and M. M. Romsdahl, “Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading,” Cancer, vol. 40, no. 2, pp. 818–831, 1977. View at Google Scholar · View at Scopus
  11. J. M. Mirra, R. Gold, J. Downs, and J. J. Eckhardt, “A new histologic appraoch to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases,” Clinical Orthopaedics and Related Research, vol. 201, pp. 214–237, 1985. View at Google Scholar
  12. D. Eefting, Y. M. Schrage, M. J. A. Geirnaerdt et al., “Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors,” American Journal of Surgical Pathology, vol. 33, no. 1, pp. 50–57, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. W. A. Chow, “Update on chondrosarcomas,” Current Opinion in Oncology, vol. 19, no. 4, pp. 371–376, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. T. Aigner, S. Müller, D. Neureiter, D. M. Illstrup, T. Kirchner, and J. Björnsson, “Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas,” Cancer, vol. 94, no. 8, pp. 2273–2281, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. Endo, T. Matsumura, T. Yamaguchi et al., “Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas,” Human Pathology, vol. 37, no. 4, pp. 471–476, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. Y. M. Schrage, I. Machado, D. Meijer et al., “COX-2 expression in chondrosarcoma: a role for celecoxib treatment?” European Journal of Cancer, vol. 46, no. 3, pp. 616–624, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. J. V. M. G. Bovée, P. C. W. Hogendoorn, J. S. Wunder, and B. A. Alman, “Cartilage tumours and bone development: molecular pathology and possible therapeutic targets,” Nature Reviews Cancer, vol. 10, no. 7, pp. 481–488, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. L. B. Rozeman, L. Hameetman, A. M. Cleton-Jansen, A. H. M. Taminiau, P. C. W. Hogendoorn, and J. V. M. G. Bovée, “Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas,” Journal of Pathology, vol. 205, no. 4, pp. 476–482, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. R. M. Terek, J. H. Healey, P. Garin-Chesa, S. Mak, A. Huvos, and A. P. Albino, “p53 mutations in chondrosarcoma,” Diagnostic Molecular Pathology, vol. 7, no. 1, pp. 51–56, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. D. J. Papachristou, M. A. Goodman, K. Cieply, J. L. Hunt, and U. N. M. Rao, “Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis,” Human Pathology, vol. 37, no. 7, pp. 890–898, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. H. M. van Beerendonk, L. B. Rozeman, A. H. M. Taminiau et al., “Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression,” Journal of Pathology, vol. 202, no. 3, pp. 359–366, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. J. Björnsson, R. A. McLeod, K. K. Unni, D. M. Ilstrup, and D. J. Pritchard, “Primary chondrosarcoma of long bones and limb girdles,” Cancer, vol. 83, no. 10, pp. 2105–2119, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. L. B. Rozeman, P. C. W. Hogendoorn, and J. V. M. G. Bovée, “Diagnosis and prognosis of chondrosarcoma of bone,” Expert Review of Molecular Diagnostics, vol. 2, no. 5, pp. 461–472, 2002. View at Google Scholar · View at Scopus
  24. H. Gelderblom, P. C. W. Hogendoorn, S. D. Dijkstra et al., “The clinical approach towards chondrosarcoma,” Oncologist, vol. 13, no. 3, pp. 320–329, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. J. V. M. G. Bovée, R. O. van der Heul, A. H. M. Taminiau, and P. C. W. Hogendoorn, “Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature,” Cancer, vol. 86, no. 9, pp. 1724–1732, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. M. L. Ostrowski and H. J. Spjut, “Lesions of the bones of the hands and feet,” American Journal of Surgical Pathology, vol. 21, no. 6, pp. 676–690, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Ogose, K. K. Unni, R. G. Swee, G. K. May, C. M. Rowland, and F. H. Sim, “Chondrosarcoma of small bones of the hands and feet,” Cancer, vol. 80, no. 1, pp. 50–59, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. A. E. Rosenberg, G. P. Nielsen, S. B. Keel et al., “Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma,” American Journal of Surgical Pathology, vol. 23, no. 11, pp. 1370–1378, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Chaabane, M. C. Bouaziz, C. Drissi, L. Abid, and M. F. Ladeb, “Periosteal chondrosarcoma,” American Journal of Roentgenology, vol. 192, no. 1, pp. W1–W6, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. Kenan, I. F. Abdelwahah, M. J. Klein, G. Hermann, and M. M. Lewis, “Lesions of juxtacortical origin (surface lesions of bone),” Skeletal Radiology, vol. 22, no. 5, pp. 337–357, 1993. View at Google Scholar · View at Scopus
  31. F. Bertoni, S. Boriani, M. Laus, and M. Campanacci, “Periosteal chondrosarcoma and periosteal osteosarcoma. Two distinct entities,” Journal of Bone and Joint Surgery. British, vol. 64, no. 3, pp. 370–376, 1982. View at Google Scholar · View at Scopus
  32. K. K. Unni, D. C. Dahlin, and J. W. Beabout, “Periosteal osteogenic sarcoma,” Cancer, vol. 37, no. 5, pp. 2476–2485, 1976. View at Google Scholar · View at Scopus
  33. T. Nojima, K. K. Unni, R. A. McLeod, and D. J. Pritchard, “Periosteal chondroma and periosteal chondrosarcoma,” American Journal of Surgical Pathology, vol. 9, no. 9, pp. 666–677, 1985. View at Google Scholar · View at Scopus
  34. P. J. Papagelopoulos, E. C. Galanis, A. F. Mavrogenis et al., “Survivorship analysis in patients with periosteal chondrosarcoma,” Clinical Orthopaedics and Related Research, no. 448, pp. 199–207, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. A. Mitchell, J. R. Rudan, and P. V. Fenton, “Juxtacortical dedifferentiated chondrosarcoma from a primary periosteal chondrosarcoma,” Modern Pathology, vol. 9, no. 3, pp. 279–283, 1996. View at Google Scholar · View at Scopus
  36. H. D. Dorfman and B. Czerniak, Bone Tumors, Mosby, St. Louis, Mo, USA, 1998.
  37. M. D. Murphey, J. J. Choi, M. J. Kransdorf, D. J. Flemming, and F. H. Gannon, “Imaging of osteochondroma: variants and complications with radiologic-pathologic correlation,” Radiographics, vol. 20, no. 5, pp. 1407–1434, 2000. View at Google Scholar · View at Scopus
  38. I. Jennes, E. Pedrini, M. Zuntini et al., “Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb),” Human Mutation, vol. 30, no. 12, pp. 1620–1627, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. R. M. Terek, “Recent advances in the basic science of chondrosarcoma,” Orthopedic Clinics of North America, vol. 37, no. 1, pp. 9–14, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. J. V. M. G. Bovée, A. M. Cleton-Jansen, W. Wuyts et al., “EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas,” American Journal of Human Genetics, vol. 65, no. 3, pp. 689–698, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. L. Hameetman, K. Szuhai, A. Yavas et al., “The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions,” Journal of the National Cancer Institute, vol. 99, no. 5, pp. 396–406, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. J. V. M. G. Bovée, “EXTra hit for mouse osteochondroma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 1813–1814, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. K. B. Jones, V. Piombo, C. Searby et al., “A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 2054–2059, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. C. E. de Andrea, M. Wiweger, F. Prins, J. V. M. G. Bovée, S. Romeo, and P. C. W. Hogendoorn, “Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma,” Laboratory Investigation, vol. 90, no. 7, pp. 1091–1101, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. C. M. A. Reijnders, C. J. F. Waaijer, A. Hamilton et al., “No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas,” American Journal of Pathology, vol. 177, no. 4, pp. 1946–1957, 2010. View at Publisher · View at Google Scholar · View at PubMed
  46. J. V. M. G. Bovée, L. J. C. M. van den Broek, A. M. Cleton-Jansen, and P. C. W. Hogendoorn, “Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma,” Laboratory Investigation, vol. 80, no. 12, pp. 1925–1933, 2000. View at Google Scholar · View at Scopus
  47. E. W. Brien, J. M. Mirra, and J. V. Luck, “Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. II. Juxtacortical cartilage tumors,” Skeletal Radiology, vol. 28, no. 1, pp. 1–20, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. P. I. J. M. Wuisman, P. C. Jutte, and T. Ozaki, “Secondary chondrosarcoma in osteochondromas. Medullary extension in 15 of 45 cases,” Acta Orthopaedica Scandinavica, vol. 68, no. 4, pp. 396–400, 1997. View at Google Scholar · View at Scopus
  49. A. Couvineau, V. Wouters, G. Bertrand et al., “PTHR1 mutations associated with Ollier disease result in receptor loss of function,” Human Molecular Genetics, vol. 17, no. 18, pp. 2766–2775, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. L. B. Rozeman, L. Sangiorgi, I. H. Briaire-de Bruijn et al., “Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C,” Human Mutation, vol. 24, no. 6, pp. 466–473, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. C. Silve and H. Jüppner, “Ollier disease,” Orphanet Journal of Rare Diseases, vol. 1, no. 1, article 37, 2006. View at Publisher · View at Google Scholar · View at PubMed
  52. S. Pannier and L. Legeai-Mallet, “Hereditary multiple exostoses and enchondromatosis,” Best Practice and Research: Clinical Rheumatology, vol. 22, no. 1, pp. 45–54, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. A. D. Mitchell, K. Ayoub, D. C. Mangham, R. J. Grimer, S. R. Carter, and R. M. Tillman, “Experience in the treatment of dedifferentiated chondrosarcoma,” Journal of Bone and Joint Surgery. British, vol. 82, no. 1, pp. 55–61, 2000. View at Google Scholar · View at Scopus
  54. R. J. Grimer, G. Gosheger, A. Taminiau et al., “Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group,” European Journal of Cancer, vol. 43, no. 14, pp. 2060–2065, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. F. Bertoni, D. Present, P. Bacchini et al., “Dedifferentiated peripheral chondrosarcomas. A report of seven cases,” Cancer, vol. 63, no. 10, pp. 2054–2059, 1989. View at Google Scholar · View at Scopus
  56. G. Bierry, A. Feydy, F. Larousserie et al., “Dedifferentiated chondrosarcoma: radiologic-pathologic correlation,” Journal de Radiologie, vol. 91, no. 3, pp. 271–279, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. J. V. M. G. Bovée, A. M. Cleton-Jansen, C. Rosenberg, A. H. M. Taminiau, C. J. Cornelisse, and P. C. W. Hogendoorn, “Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis,” Journal of Pathology, vol. 189, no. 4, pp. 454–462, 1999. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Hameed, C. Ulger, D. Yasar et al., “Genome profiling of chondrosarcoma using oligonucleotide array-based comparative genomic hybridization,” Cancer Genetics and Cytogenetics, vol. 192, no. 2, pp. 56–59, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. L. B. Rozeman, I. H. B. de Bruijn, P. Bacchini et al., “Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes,” Modern Pathology, vol. 22, no. 11, pp. 1489–1498, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. I. D. Dickey, P. S. Rose, B. Fuchs et al., “Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes,” Journal of Bone and Joint Surgery. American, vol. 86, no. 11, pp. 2412–2418, 2004. View at Google Scholar · View at Scopus
  61. Y. Nakashima, K. K. Unni, T. C. Shives, R. G. Swee, and D. C. Dahlin, “Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases,” Cancer, vol. 57, no. 12, pp. 2444–2453, 1986. View at Google Scholar · View at Scopus
  62. A. H. Salvador, J. W. Beabout, and D. C. Dahlin, “Mesenchymal chondrosarcoma—observations on 30 new cases,” Cancer, vol. 28, no. 3, pp. 605–615, 1971. View at Google Scholar · View at Scopus
  63. K. Devoe and N. Weidner, “Immunohistochemistry of small round-cell tumors,” Seminars in Diagnostic Pathology, vol. 17, no. 3, pp. 216–224, 2000. View at Google Scholar · View at Scopus
  64. J. C. Fanburg-Smith, A. Auerbach, J. S. Marwaha, Z. Wang, and E. J. Rushing, “Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and β-catenin, Sox9, and osteocalcin immunostaining of 22 cases,” Human Pathology, vol. 41, no. 5, pp. 653–662, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. S. Naumann, P. A. Krallman, K. Krishnan Unni, M. E. Fidler, J. R. Neff, and J. A. Bridge, “Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma,” Modern Pathology, vol. 15, no. 5, pp. 572–576, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. Y. K. Park, H. R. Park, S. G. Chi et al., “Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma,” Oncology Reports, vol. 7, no. 5, pp. 1041–1047, 2000. View at Google Scholar · View at Scopus
  67. J. Bjornsson, K. K. Unni, D. C. Dahlin, J. W. Beabout, and F. H. Sim, “Clear cell chondrosarcoma of bone: observations in 47 cases,” American Journal of Surgical Pathology, vol. 8, no. 3, pp. 223–230, 1984. View at Google Scholar · View at Scopus
  68. M. S. Collins, T. Koyama, R. G. Swee, and C. Y. Inwards, “Clear cell chondrosarcoma: radiographic, computed tomographic and magnetic resonance findings in 34 patients with pathologic correlation,” Skeletal Radiology, vol. 32, no. 12, pp. 687–694, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. P. E. Swanson, “Clear cell tumors of bone,” Seminars in Diagnostic Pathology, vol. 14, no. 4, pp. 281–291, 1997. View at Google Scholar · View at Scopus
  70. R. K. Kalil, C. Y. Inwards, K. K. Unni et al., “Dedifferentiated clear cell chondrosarcoma,” American Journal of Surgical Pathology, vol. 24, no. 8, pp. 1079–1086, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Söder, A. M. Oliveira, C. Y. Inwards, S. Müller, and T. Aigner, “Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma,” Pathology, vol. 38, no. 1, pp. 35–38, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. Y. K. Park, H. R. Park, S. G. Chi, S. Ushigome, and K. K. Unni, “Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma,” International Journal of Oncology, vol. 19, no. 2, pp. 353–357, 2001. View at Google Scholar · View at Scopus
  73. J. Nishio, J. D. Reith, A. Ogose, G. Maale, J. R. Neff, and J. A. Bridge, “Cytogenetic findings in clear cell chondrosarcoma,” Cancer Genetics and Cytogenetics, vol. 162, no. 1, pp. 74–77, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus